REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/10/2025
Back to search
Official data from USPTO
PROGENTEC DIAGNOSTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PROGENTEC DIAGNOSTICS
ST13
US500000088258685Class
35, 38, 42
Filing
88258685
Registration
6005176
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
03/10/2025
Trademark type
Word
Nice classes
35, 38, 42
Filing date
01/11/2019
Registration date
03/10/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/10/2020
Last transaction
03/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/11/2019
First use in commerce
01/11/2019
Drawing code
4
Owner type
03
Owner location
Oklahoma City, OK
Examiner
WELLS, KELLEY
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Progentec Diagnostics, Inc.
Representatives
EDWIN FLORES CHALKER FLORES, LLP
Technical classification
Nice Classes
Class 35Class 38Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of clinical trialspatient enrollment tracking and monitoringpharmaceutical and medicine tracking; business consulting and management in the field of clinical trialscompilation of statistics and clinical trial data for business purposes; preparing and placing advertisements for others; providing referrals of patients for enrollment in clinical trials; business consulting and management in the field of clinical trialsclinical data management; marketing consultingdesigning and developing advertising and marketing for others in relation to clinical trials and medical research; online business networking services for clinical research professionals involved in the clinical study of medical products including pharmaceuticalsbiologicsdiagnostic tools and medical devices; management and compilation of computerized databases of clinical research professionals to provide ability to contact clinical research professionals electronically including by email to evaluate clinical study protocolstake part in clinical studies and recruit patients to take part in clinical studies; promoting public awareness of the need for improved prevention and treatment of illnessesfor improved health care quality and efficiency; public advocacy to promote awareness of the need for assuring patients safe access to affordable medicine; promoting technical and scientific investigationresearchexperimentation in the field of advancement of the application of scientific discovery in connection with pharmaceuticalsdiagnostic toolsbiomarkers and medical devices; and public advocacy to promote awareness of scientificresearch and medical advances
Class 38
Providing access to a computer database; providing on-line forums for transmission of messages among computer and mobile device users concerning patientdoctor and caregiver information in order to generatemanage and share medical information; and provision of access to databases
Class 42
Medical and scientific research and development in the field of medicinethe preventiontreatmentmanagement of illness and health care delivery; medical and scientific research in the field of illness and diagnosis; technical research in the field of pharmaceutical studies; pharmaceutical product evaluation; development of pharmaceutical toolspreparations and medicines; conducting early evaluations in the field of new pharmaceuticals; medical and scientific researchconducting clinical trials for others; chemicalbiochemicalbiological and bacteriological research and analysis; biological research; medical laboratories; scientific and technological services and research and design relating theretoscientific analysis in the fields of pharmaceutical and medical device /diagnostics development; scientific research for medical purposes; design and development of computer software; research services for medical and pharmaceutical purposes; design and development of new products/services for others; design and development of computer tracking and diagnostic tools; conducting clinical trials for others; medical laboratory services; providing information about the results of clinical trials for pharmaceutical products; electronic data storage; and working on and evaluation of biomarkers and diagnostic products; and providing an online network service that enables users to share data in the field of healthcare; non-downloadable computer software provided via the Internet as an Application Service Provider ASP-hosted solution for the collectioneditingorganizingmodifyingbook markingtransmissionstorage and sharing of data and information
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/24/2019
PUBO
PUBLISHED FOR OPPOSITION
12/24/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/04/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/18/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
11/18/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/18/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
11/18/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/18/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/07/2019
GNRT
NON-FINAL ACTION E-MAILED
05/07/2019
CNRT
NON-FINAL ACTION WRITTEN
05/07/2019
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
04/25/2019
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
04/23/2019
ALIE
ASSIGNED TO LIE
04/03/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/13/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
03/13/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/13/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
03/13/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/13/2019
DOCK
ASSIGNED TO EXAMINER
03/05/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/02/2019
NWAP
NEW APPLICATION ENTERED
01/15/2019
Continuous trademark protection
Get notified about every new filing that threatens PROGENTEC DIAGNOSTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.